- Home
- CUE vs AP Comparison
CUE vs AP Comparison
Compare CUE & AP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- AP
- Stock Information
- Founded
- CUE 2014
- AP 1929
- Country
- CUE United States
- AP United States
- Employees
- CUE N/A
- AP N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- AP Fluid Controls
- Sector
- CUE Health Care
- AP Industrials
- Exchange
- CUE Nasdaq
- AP Nasdaq
- Market Cap
- CUE 58.9M
- AP 54.7M
- IPO Year
- CUE 2018
- AP N/A
- Fundamental
- Price
- CUE $0.64
- AP $3.43
- Analyst Decision
- CUE Strong Buy
- AP
- Analyst Count
- CUE 3
- AP 0
- Target Price
- CUE $3.00
- AP N/A
- AVG Volume (30 Days)
- CUE 163.7K
- AP 68.7K
- Earning Date
- CUE 05-12-2025
- AP 05-12-2025
- Dividend Yield
- CUE N/A
- AP N/A
- EPS Growth
- CUE N/A
- AP N/A
- EPS
- CUE N/A
- AP 0.22
- Revenue
- CUE $7,991,000.00
- AP $412,355,000.00
- Revenue This Year
- CUE N/A
- AP N/A
- Revenue Next Year
- CUE $25.99
- AP N/A
- P/E Ratio
- CUE N/A
- AP $13.97
- Revenue Growth
- CUE 13.83
- AP N/A
- 52 Week Low
- CUE $0.45
- AP $0.74
- 52 Week High
- CUE $1.99
- AP $3.43
- Technical
- Relative Strength Index (RSI)
- CUE 37.72
- AP 64.20
- Support Level
- CUE $0.61
- AP $2.94
- Resistance Level
- CUE $0.71
- AP $3.13
- Average True Range (ATR)
- CUE 0.06
- AP 0.28
- MACD
- CUE -0.00
- AP 0.02
- Stochastic Oscillator
- CUE 17.84
- AP 74.19
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About AP Ampco-Pittsburgh Corporation
Ampco-Pittsburgh Corp is manufacturing and selling engineered, specialty metal products and customized equipment. It operates in two business segments namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, and other metals whereas, the Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, and Buffalo Pumps. The company generates a majority of its revenue from the Forged and Cast Engineered Products segment. It has a business presence in the United States and other countries.